Cargando…

Correction: The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy

Detalles Bibliográficos
Autores principales:	Cheng, Yan-jiao, Wang, Miao, Wang, Jia, Cui, Zhao, Zhao, Ming-hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074696/ https://www.ncbi.nlm.nih.gov/pubmed/37020299 http://dx.doi.org/10.1186/s40001-023-01110-w

Ejemplares similares

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy
por: Ge, Yong-Chun, et al.
Publicado: (2016)

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
por: Chen, Yang, et al.
Publicado: (2023)

Anti-PLA(2)R Antibodies in Chinese Patients with Membranous Nephropathy
por: Li, Xin, et al.
Publicado: (2016)

Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study
por: Pang, Lu, et al.
Publicado: (2017)

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy
por: Hihara, Kei, et al.
Publicado: (2016)

Horseshoe kidney with PLA2R-positive membranous nephropathy
por: Shi, Shuai-Shuai, et al.
Publicado: (2021)

Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
por: Logt, Anne-Els van de, et al.
Publicado: (2021)

Membranous nephropathy PLA2R+ associated with Chagas disease
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2015)

PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis
por: Dhaouadi, Tarak, et al.
Publicado: (2020)

Successful treatment of PLA(2)R1-antibody positive membranous nephropathy with ocrelizumab
por: Schmidt, Tilman, et al.
Publicado: (2020)

The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
por: Kukuy, Olga Lesya, et al.
Publicado: (2023)

Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years
por: Pourcine, Franck, et al.
Publicado: (2017)

Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy
por: Wang, Yu, et al.
Publicado: (2017)

Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
por: Geara, Abdallah S., et al.
Publicado: (2021)

Correction to: The association between variants in PLA2R and HLA-DQA1 and renal outcomes in patients with primary membranous nephropathy in Western China
por: Fan, Shulei, et al.
Publicado: (2021)

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels
por: Sun, Yuemeng, et al.
Publicado: (2022)

Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
por: Chen, Ruiying, et al.
Publicado: (2022)

Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis
por: Li, Weiying, et al.
Publicado: (2018)

Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
por: Ramachandran, R., et al.
Publicado: (2017)

Response to immunosuppressive therapy in PLA(2)R- associated and non-PLA(2)R- associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study
por: Wang, Jia, et al.
Publicado: (2017)

The value of PLA2R antigen and IgG subclass staining relative to anti-PLA2R seropositivity in the differential diagnosis of membranous nephropathy
por: Bajcsi, Dóra, et al.
Publicado: (2023)

Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease
por: Jagannathan, Geetha, et al.
Publicado: (2022)

Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
por: Jatem-Escalante, Elias, et al.
Publicado: (2021)

PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy
por: Ragy, Omar, et al.
Publicado: (2023)

Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer
por: Deng, Le, et al.
Publicado: (2022)

Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
por: Liu, Wenbin, et al.
Publicado: (2019)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Du, Yu, et al.
Publicado: (2014)

Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy
por: Zhu, Huizi, et al.
Publicado: (2022)

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
por: Guo, Yaling, et al.
Publicado: (2020)

A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy
por: Zhang, Pingna, et al.
Publicado: (2021)

Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
por: Baker, Lyle W., et al.
Publicado: (2021)

Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
por: Fresquet, Maryline, et al.
Publicado: (2022)

Association between PLA2R gene polymorphism and idiopathic membranous nephropathy in Heilongjiang Chinese
por: Tian, Tian, et al.
Publicado: (2023)

Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
por: Xue, Cheng, et al.
Publicado: (2023)

Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults
por: Wu, Xueping, et al.
Publicado: (2018)

Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
por: Porcelli, Brunetta, et al.
Publicado: (2020)

Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
por: Wang, Song, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p565a9dnjm1gq1r9fftmbc4tt8